(Q39348282)

English

Melanoma cells become resistant to NK-cell-mediated killing when exposed to NK-cell numbers compatible with NK-cell infiltration in the tumor.

scientific article published on 25 May 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22585684%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Melanoma cells become resistant to NK-cell-mediated killing when exposed to NK-cell numbers compatible with NK-cell infiltration in the tumor (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22585684%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22585684%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22585684%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Fabio Facchetti

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22585684%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22585684%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

7

object named as

Silvia Lonardi

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22585684%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

1

object named as

Mirna Balsamo

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22585684%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Alessandro Moretta

9

object named as

Alessandro Moretta

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22585684%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

author name string

Monica Parodi

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22585684%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Gabriella Pietra

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22585684%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Claudia Manzini

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22585684%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Raffaella Augugliaro

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22585684%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Lorenzo Moretta

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22585684%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Maria Cristina Mingari

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22585684%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

language of work or name

0 references

publication date

25 May 2012

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22585684%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

European Journal of Immunology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22585684%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

42

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22585684%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22585684%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

1833-1842

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22585684%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Differential tumor surveillance by natural killer (NK) and NKT cells.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142179

21 January 2018

In vivo natural killer cell activities revealed by natural killer cell-deficient mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142179

21 January 2018

Natural cytotoxic activity of peripheral-blood lymphocytes and cancer incidence: an 11-year follow-up study of a general population

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142179

21 January 2018

NCRs and DNAM-1 mediate NK cell recognition and lysis of human and mouse melanoma cell lines in vitro and in vivo.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142179

21 January 2018

Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142179

21 January 2018

Killer Ig-like receptor-mediated control of natural killer cell alloreactivity in haploidentical hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142179

21 January 2018

Functions of natural killer cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142179

21 January 2018

Early liaisons between cells of the innate immune system in inflamed peripheral tissues.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142179

21 January 2018

Human natural killer cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142179

21 January 2018

The interaction of human natural killer cells with either unpolarized or polarized macrophages results in different functional outcomes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142179

21 January 2018

Learning how to discriminate between friends and enemies, a lesson from Natural Killer cells.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142179

21 January 2018

NK cell recognition

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142179

21 January 2018

Synergy among receptors on resting NK cells for the activation of natural cytotoxicity and cytokine secretion

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142179

21 January 2018

Innate or adaptive immunity? The example of natural killer cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142179

21 January 2018

Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142179

21 January 2018

ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142179

21 January 2018

Identification of PVR (CD155) and Nectin-2 (CD112) as cell surface ligands for the human DNAM-1 (CD226) activating molecule

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142179

21 January 2018

The role of NK cell recognition of nectin and nectin-like proteins in tumor immunosurveillance

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142179

21 January 2018

Human leukocyte antigen-B-associated transcript 3 is released from tumor cells and engages the NKp30 receptor on natural killer cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142179

21 January 2018

The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humans

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142179

21 January 2018

NKp44, a novel triggering surface molecule specifically expressed by activated natural killer cells, is involved in non-major histocompatibility complex-restricted tumor cell lysis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142179

21 January 2018

Enhanced in vivo growth of lymphoma tumors in the absence of the NK-activating receptor NKp46/NCR1.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142179

21 January 2018

Identification of 4Ig-B7-H3 as a neuroblastoma-associated molecule that exerts a protective role from an NK cell-mediated lysis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142179

21 January 2018

Interleukin-12 and the regulation of innate resistance and adaptive immunity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142179

21 January 2018

Distinct roles of IL-12 and IL-15 in human natural killer cell activation by dendritic cells from secondary lymphoid organs

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142179

21 January 2018

Functions of γC cytokines in immune homeostasis: current and potential clinical applications

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142179

21 January 2018

Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142179

21 January 2018

IL-18-induced CD83+CCR7+ NK helper cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142179

21 January 2018

IL-12 or IL-4 prime human NK cells to mediate functionally divergent interactions with dendritic cells or tumors

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142179

21 January 2018

Transforming growth factor beta 1 inhibits expression of NKp30 and NKG2D receptors: consequences for the NK-mediated killing of dendritic cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142179

21 January 2018

Melanoma-associated fibroblasts modulate NK cell phenotype and antitumor cytotoxicity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142179

21 January 2018

Natural killer cells kill human melanoma cells with characteristics of cancer stem cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142179

21 January 2018

GPR56 as a novel marker identifying the CD56dull CD16+ NK cell subset both in blood stream and in inflamed peripheral tissues.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142179

21 January 2018

GPR56, an atypical G protein-coupled receptor, binds tissue transglutaminase, TG2, and inhibits melanoma tumor growth and metastasis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142179

21 January 2018

Beyond the increasing complexity of the immunomodulatory HLA-G molecule

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142179

21 January 2018

NK cell recognition of non-classical HLA class I molecules

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142179

21 January 2018

IFN-gamma protects short-term ovarian carcinoma cell lines from CTL lysis via a CD94/NKG2A-dependent mechanism

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142179

21 January 2018

HLA-G expression in malignant melanoma.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142179

21 January 2018

Clinical relevance and functional implications for human leucocyte antigen-g expression in non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142179

21 January 2018

Interferon-gamma down-regulates NKG2D ligand expression and impairs the NKG2D-mediated cytolysis of MHC class I-deficient melanoma by natural killer cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142179

21 January 2018

1,25-Dihydroxyvitamin D₃ enhances NK susceptibility of human melanoma cells via Hsp60-mediated FAS expression

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142179

21 January 2018

Natural killer cell-directed therapies: moving from unexpected results to successful strategies

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142179

21 January 2018

IL-15Ralpha chaperones IL-15 to stable dendritic cell membrane complexes that activate NK cells via trans presentation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142179

21 January 2018

Treatment of hepatocellular carcinoma with adeno-associated virus encoding interleukin-15 superagonist

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142179

21 January 2018

Profound Coordinated Alterations of Intratumoral NK Cell Phenotype and Function in Lung Carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142179

21 January 2018

Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142179

21 January 2018

The tryptophan catabolite L-kynurenine inhibits the surface expression of NKp46- and NKG2D-activating receptors and regulates NK-cell function

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142179

7 January 2021

based on heuristic

inferred from DOI database lookup

HLA-E and HLA-G expression in classical HLA class I-negative tumors is of prognostic value for clinical outcome of early breast cancer patients

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142179

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39348282&oldid=2008455349"